Frisby Research
Client Login
Back to public dashboard

Oncology Biotech Companies and Upcoming Catalysts

Public company snapshots and catalyst previews organized by sector.

Public Company List

TickerCompanyLead AssetIndicationStageNext Catalyst
CVMCel-Sci CorpCEL-SCI CorporationMultikine Phase 3 Data Published in Peer-Reviewed Scientific Journal Pathology and Oncology ResearchPhase 32026-08
BOLDBoundless Bio IncBBI-825Solid TumorPhase 12026-09-30
ACTUActuate Therapeutics Inc9-ING-41Pancreatic AdenocarcinomaPhase 22026-12-31
XLOXilio Therapeutics IncXTX202Advanced Solid TumorPhase 1 | Phase 22027-02
BOLTBolt Biotherapeutics IncBDC-1001Metastatic Breast Cancer | HER2-positive Breast CancerPhase 22027-05
SNSESensei Biotherapeutics IncSNS-301Squamous Cell Carcinoma of the Head and NeckPhase 22027-06
KTTAPasithea Therapeutics CorpPAS-004 CapsulesRAS Mutation | NF1 Mutation | RAF Mutation | Advanced Solid TumorsPhase 12027-09
OSTXOS Therapies IncTrifluridine/TipiracilRefractory Metastatic Colorectal CancerPhase 32027-09
NXTCNextcure IncOxaliplatinPancreatic CancerPhase 22028-02
CRISCuris IncCUDC-907Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc AlterationsPhase 22028-07-31
HOWLWerewolf Therapeutics IncWTX-330Advanced or Metastatic Solid Tumors | Non-Hodgkin LymphomaPhase 12028-08
BCABBioAtla IncCAB-AXL-ADCNon-Small-Cell Lung CancerPhase 22028-09-15
PSTVPlus Therapeutics IncPirtobrutinibChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaPhase 32030-04-01
KAPAKairos Pharma LtdENV105Phase II Prostate Cancer Trial and for Phase I Non-Small Cell Lung Cancer for ENV105Approvedn/a
LIXTLixte Biotechnology Holdings IncLB-100 for InjectionTumors | Neoplasms | CancerPhase 1Data Readout
TCRTAlaunos Therapeutics IncIndibulinMetastatic Breast CancerPhase 1n/a
TVRDTvardi Therapeutics IncTTI-101Head and Neck Squamous Cell CarcinomaApprovedn/a
XBIOXenetic Biosciences IncSodium CridanimodEndometrial CancerPhase 2Corporate Update

Upcoming Catalysts

Company Ticker Catalyst Timing Asset Confidence
Mustang Bio Inc MBIO Clinical Trial Completion 2026-08-06 cyclophosphamide Low
Boundless Bio Inc BOLD Clinical Trial Completion 2026-09-30 BBI-355 Low
Atossa Therapeutics Inc ATOS Clinical Trial Completion 2026-11 (Z)-endoxifen Low
Psyence Biomedical Ltd PBM Clinical Trial Completion 2026-12-30 Psilocybin therapy Low
Actuate Therapeutics Inc ACTU Clinical Trial Completion 2026-12-31 FOLFIRNINOX Low
IN8bio Inc INAB Clinical Trial Completion 2027-01 EAGD T-cell infusion (Phase I) Low
Intensity Therapeutics Inc INTS Clinical Trial Completion 2027-01 Pirtobrutinib Low
Apollomics Inc APLM Clinical Trial Completion 2027-01-31 APL-101 Low
Xilio Therapeutics Inc XLO Clinical Trial Completion 2027-02 XTX301 Low
60 Degrees Pharmaceuticals Inc SXTP Clinical Trial Completion 2027-04-01 NPX372 Low
Bolt Biotherapeutics Inc BOLT Clinical Trial Completion 2027-05 BDC-4182 Low
Telomir Pharmaceuticals Inc TELO Clinical Trial Completion 2027-05 Zn-Telomir Low
Sensei Biotherapeutics Inc SNSE Clinical Trial Completion 2027-06 SNS-101 (anti-VISTA) Low
Cellectar Biosciences Inc CLRB Data Readout Timing not specified n/a Low
Cellectar Biosciences Inc CLRB Presentation Timing not specified n/a Low
Lixte Biotechnology Holdings Inc LIXT Corporate Update Timing not specified LB-100 Low
Xenetic Biosciences Inc XBIO Corporate Update Timing not specified n/a Low
Xenetic Biosciences Inc XBIO Data Readout Timing not specified n/a Low

Get the weekly biotech catalyst watchlist.

Subscribe